Evidence was obtained demonstrating that application of siRNA targeting cathepsin L (CatL siRNA) intraperitoneally (i.p.)caused a marked decrease in the development of CY-induced diabetes in NOD mice showing a high level of blood glucose (Figure 5A). This evidence concerns the gene CTSL and diabetes mellitus.